Advertisement

Obstructive sleep apnoea, type 2 diabetes and cardiovascular risk factors

Published:January 09, 2017DOI:https://doi.org/10.1016/j.ejim.2016.12.018
      Obstructive sleep apnea (OSA), characterized by episodes of upper airway collapses and sleep fragmentation, is the most prevalent sleep-breathing-disorder. Recent researches suggest the overall prevalence of OSA ranges from 9% to 38% in the general adult population [
      • Senaratna C.V.
      • et al.
      Prevalence of obstructive sleep apnea in the general population: a systematic review.
      ]. Many studies have demonstrated the independent relationship between OSA and cardiovascular (CV) diseases [
      • Pamidi S.
      • Tasali E.
      Obstructive sleep apnea and type 2 diabetes: is there a link?.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Senaratna C.V.
        • et al.
        Prevalence of obstructive sleep apnea in the general population: a systematic review.
        Sleep Med Rev. 2016; https://doi.org/10.1016/j.smrv.2016.07.002
        • Pamidi S.
        • Tasali E.
        Obstructive sleep apnea and type 2 diabetes: is there a link?.
        Front Neurol. 2012; 3https://doi.org/10.3389/fneur.2012.00126
        • Pedrosa R.P.
        • Drager L.F.
        • Gonzaga C.C.
        • Sousa M.G.
        • de Paula L.K.
        • Amaro A.C.
        • et al.
        Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.
        Hypertension. 2011; 58: 811-817
        • Garcia-Rio F.
        • Alonso-Fernandez A.
        • Armada E.
        • Mediano O.
        • Lores V.
        • Rojo B.
        • et al.
        CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction.
        Int J Cardiol. 2013; 168: 1328-1335
        • Mansukhani M.P.
        • Bellolio M.F.
        • Kolla B.P.
        • Enduri S.
        • Somers V.K.
        • Stead L.G.
        Worse outcome after stroke in patients with obstructive sleep apnea: an observational cohort study.
        J Stroke Cerebrovasc Dis. 2011; 20: 401-405
        • American Diabetes Association
        Classification and diagnosis of diabetes. Sec. 2.
        in: Standards of medical care in diabetes—2016. Diabetes care. 39 (Suppl. 1). 2016: S13-S22
        • Lamberts M.
        • Nielsen O.W.
        • Lip G.Y.
        • Ruwald M.H.
        • Christiansen C.B.
        • Kristensen S.L.
        • et al.
        Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults.
        J Intern Med. 2014; 276: 659-666
        • Iturriaga R.
        • Moya E.A.
        • Del Rio R.
        Cardiorespiratory alterations induced by intermittent hypoxia in a rat model of sleep apnea.
        Adv Exp Med Biol. 2010; 669: 271-274